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Purpose
A lower daily pill burden may improve adherence to
antiretroviral treatment (ART) and improve outcomes.
The goal of this study was to assess differences in
adherence rates based on the number of pills taken per
day and to evaluate how adherence correlates with the
risk of hospitalization.
Methods
This analysis examined commercially insured patients in
the LifeLink claims database. Patients were selected if
they had a diagnosis of HIV/AIDS (ICD-9-CM code
042.xx) between 6/1/2006 and 12/31/2008 and received
a complete ART regimen defined as 2 nucleoside/
nucleotide reverse transcriptase inhibitors (NRTIs) along
with a third agent (NNRTI, protease inhibitor, CCR5
antagonist, or integrase inhibitor). Patients were grouped
according to their daily pill count: one, two, or three or
more pills a day, and were required to receive their regi-
men for at least 60 days. Outcomes included adherence
(both absolute and at pre-specified thresholds) and rates
of hospitalization. Adherence was measured as a propor-
tion (medication possession ratio) by dividing the days
the patient received a complete regimen by the days
between the start and end of the regimen. Logistic
regressions were undertaken to assess the relationship
between pills per day and adherence and hospitalization
while controlling for demographics, comorbidities, and
ART-naïve (vs. experienced) status.
Results
7,073 patients met the study inclusion criteria, among
whom 33.4%, 5.8%, and 60.8% received one, two, or
three or more pills a day, respectively. 1,829 (20.5%)
patients were excluded because they had an incomplete
regimen. Approximately 47% of patients receiving one
pill a day achieved ≥95% adherence, compared to 41%
of patients receiving two pills a day, and 34% of
patients receiving three or more pills a day. Based on
regression results, patients receiving one pill a day
were 61% more likely to reach a 95% adherence
threshold vs. patients receiving three or more pills a
day (odds ratio [OR]=1.61, P<0.001). Regardless of
number of pills per day received, patients were 40%
less likely to have a hospitalization if they were adher-
ent to therapy (OR=0.62, P<0.001). Patients receiving
one pill a day were 21% less likely to have a hospitali-
zation vs. patients receiving three or more pills a day
(OR=0.770, P<0.01).
Conclusions
We found receiving an ART regimen consisting of one
pill a day was associated with better adherence and a
lower risk of hospitalization.
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